Publication | Open Access
Bortezomib for the Treatment of Mantle Cell Lymphoma
330
Citations
6
References
2007
Year
Bortezomib received regular approval for the treatment of patients with mantle cell lymphoma in relapse after prior therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1